Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Share-based Compensation (2010 - 2026)

Incyte's (INCY) quarterly Share-based Compensation came in at $67.3 million in Q2 2026, up 4.11% YoY from $64.6 million in Q2 2025, and up 4.89% on a QoQ basis from $64.1 million in Q1 2026.

Analysis

Incyte (INCY) Share-based Compensation (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Share-based Compensation data on file, last reported at $67.3 million in Q2 2026.

  • Quarterly Share-based Compensation rose 4.11% year-over-year to $67.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $255.1 million (down 7.3% YoY) and the FY2025 annual result came in at $249.3 million, down 6.28% from the prior year.
  • Share-based Compensation rose to $67.3 million in Q2 2026, from $64.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $77.9 million in Q3 2024 to a low of $43.8 million in Q1 2022.
  • A 5-year average of $58.4 million and a median of $59.9 million in 2023 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2022 — Share-based Compensation soared 118.9% — and 2025, when it slipped 20.95%.
  • Tracing INCY's Share-based Compensation over 5 years: stood at $52.7 million in 2022, then rose by 13.88% to $60.0 million in 2023, then gained by 19.55% to $71.7 million in 2024, then fell by 13.33% to $62.2 million in 2025, then advanced by 8.21% to $67.3 million in 2026.
  • The last three Share-based Compensation figures came in at $67.3 million (Q2 2026), $64.1 million (Q1 2026), and $62.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 67.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67.26 Mn
Mar 31, 2026 64.13 Mn
Dec 31, 2025 62.16 Mn
Sep 30, 2025 61.60 Mn
Jun 30, 2025 64.61 Mn
Mar 31, 2025 60.98 Mn
Dec 31, 2024 71.72 Mn
Sep 30, 2024 77.92 Mn
Jun 30, 2024 56.64 Mn
Mar 31, 2024 59.78 Mn
Dec 31, 2023 59.99 Mn
Sep 30, 2023 48.00 Mn
Jun 30, 2023 54.52 Mn
Mar 31, 2023 53.38 Mn
Dec 31, 2022 52.68 Mn
Sep 30, 2022 45.40 Mn
Jun 30, 2022 46.50 Mn
Mar 31, 2022 43.84 Mn
Dec 31, 2021 48.22 Mn
Sep 30, 2021 42.70 Mn